Skip to main content

Table 1 Summary of the laboratory data of the patient on admission

From: Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein–Barr virus infection: a case report and review of the literature

Investigations

Values

Reference range

Units

White blood cells

8.3

3.3–8.6

× 1000/μL

Neutrophils

67.0

41.7–74.1

%

Hemoglobin

13.9

11.6–14.8

g/dL

Platelet counts

32.7

15.8–34.8

× 10000/μL

PT-INR

1.1

0.9–1.1

 

APTT

26.2

24.5–39.7

seconds

Total protein

7.4

6.6–8.1

g/dL

Albumin

4.0

4.1–5.1

g/dL

Blood-urea-nitrogen

29

8–20

mg/dL

Creatinine

0.78

0.46–0.79

mg/dL

Na

142

138–145

mEq/L

K

4.7

3.6–4.8

mEq/L

Lactate dehydrogenase

289

124–222

U/L

Aspartate aminotransferase

22

13–30

U/L

Alanine aminotransferase

13

7–23

U/L

Total bilirubin

0.7

0.4–1.5

mg/dL

C-reactive protein

1.47

< 0.14

mg/dL

HbA1c

6.6

4.9–6.0

%

sIL-2R

620

145–519

U/mL

EBV-VCA IgG

160

< 10

Fold

EBV-VCA IgM

< 10

< 10

Fold

EBV-EBNA

40

< 10

Fold

  1. APTT activated partial thromboplastin time, EBNA EBV-nuclear antigen, EBV Epstein–Barr virus, EBV-VCA Epstein–Barr virus-viral capsid antigen, HbA1c glycated hemoglobin, IgA immunoglobulin A, IgG immunoglobulin G, PT-INR prothrombin time-international normalized ratio, sIL-2R soluble interleukin-2 receptor